| Authors: |
Tarhini AA; Department of Immunology, H Lee Moffitt Cancer Center and Research Center, Tampa, Florida, USA ahmad.tarhini@moffitt.org.; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Khaksar MA; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Chen Z; Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Lee SJ; Harvard Medical School, Boston, Massachusetts, USA., Stephen Hodi F; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Li T; Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Yoder SJ; Molecular Genomics Core Facility, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Streicher H; Cancer Therapy Evaluation Program, National Cancer Institute, Baltimore, Maryland, USA., Sondak VK; Department of Cutaneous Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Kirkwood JM; Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Wang X; Department of Biostatistics and Bioinformatics, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Kanetsky PA; Department of Cancer Epidemiology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. |
